Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

NCT05761444 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Atozet 10/40 mg or 10/80 mg
DRUG: Lipitor 40 mg or 80 mg

Sponsor

Organon and Co

Collaborators

[object Object]